Benzinga | May 11, 2021 07:00AM EDT

Bausch + Lomb Highlights National Eye Institute Data Showing AREDS2 Nutrient Formula 'Continues To Reduce The Risk Of Moderate To Advanced Age-Related Macular Degeneration Progression'

LAVAL, Quebec, May 11, 2021 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (TSX:BHC) ("Bausch Health"), today announced new data from the National Eye Institute (NEI) 10-Year Follow-on Study Results of the Age-Related Eye Disease Study 2 (AREDS2), which reaffirms the clinical outcomes of the AREDS2 study. Based on this data, the NEI continues to recommend a specific nutrient formula to help reduce the risk of progression in patients with moderate to advanced Age-Related Macular Degeneration (AMD).1 That formula is currently found in